Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents.
暂无分享,去创建一个
S. Pocock | T. Henry | M. Krucoff | G. Dangas | R. Mehran | A. Kini | U. Baber | A. Colombo | D. Cohen | C. Gibson | P. Steg | D. Moliterno | S. Sartori | J. Chandrasekhar | B. Witzenbichler | C. Gibson | I. Mastoris | G. Giustino | A. Chieffo | C. Ariti | Jennifer Yu | Mitchell W. Krucoff | D. Cohen
[1] T. Henry,et al. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study. , 2015, Circulation. Cardiovascular quality and outcomes.
[2] G. Stone,et al. Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] G. Grunwald,et al. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. , 2014, American heart journal.
[4] P. Castiglioni,et al. Gender Differences in Illness Behavior After Cardiac Surgery , 2014, Journal of cardiopulmonary rehabilitation and prevention.
[5] E. Peterson,et al. Sex‐Based Differences in Outcomes After Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Report From TRANSLATE‐ACS , 2014, Journal of the American Heart Association.
[6] R. Verbrugge,et al. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. , 2014, Journal of women's health.
[7] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.
[8] Hassan Khan,et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. , 2013, European heart journal.
[9] Mandeep Singh,et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.
[10] T. Brennan,et al. Gender and racial disparities in adherence to statin therapy: a meta-analysis. , 2013, American heart journal.
[11] Pamala A. Pawloski,et al. Patient Characteristics Associated with Medication Adherence , 2013, Clinical Medicine & Research.
[12] Laura Mauri,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[13] G. Levine,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.
[14] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[15] Rowena J Dolor,et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.
[16] S. Pocock,et al. A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.
[17] L. Newby,et al. Twelve-Year Follow-Up of American Women's Awareness of Cardiovascular Disease Risk and Barriers to Heart Health , 2010, Circulation. Cardiovascular quality and outcomes.
[18] Inger Ekman,et al. Adherence to medication according to sex and age in the CHARM programme , 2009, European journal of heart failure.
[19] K. Alexander,et al. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). , 2009, The American journal of cardiology.
[20] Fred S Apple,et al. Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.
[21] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[22] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.
[23] E. Antman,et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). , 2006, American heart journal.
[24] M. Pfeffer,et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial , 2005, The Lancet.
[25] Z. Vered,et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? , 2004, American heart journal.
[26] P. Schuster,et al. Gender Differences in Cardiac Rehabilitation Patients , 1991, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.